Algicon 500 mg+100 mg (Chewable Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Sodium alginate potassium bicarbonate |
| Company | Leon pharmaceuticals ltd |
| Also available as |
Title
Algicon (Sodium Alginate and Potassium Bicarbonate)
Categories
- Medicine
- Digestive Health
- Antacid
Description
Algicon is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus. It can be used to treat symptoms of gastroesophageal reflux during concomitant treatment with or following the withdrawal of acid suppressing therapy. The pharmacology involves the formation of a gel by Sodium Alginate in reaction with stomach acid, and the formation of carbon dioxide bubbles by Potassium Bicarbonate. The raft formed by this combination prevents acid reflux and lasts for up to 4 hours. Algicon is available in tablet and suspension forms for different age groups, with precautions for patients with renal impairment and congestive cardiac failure. It has contraindications for patients with known hypersensitivity to Sodium Alginate and Potassium Bicarbonate. The product has a therapeutic class of Antacids and should be stored below 30°C temperature, away from light & moisture, and out of the reach of children.
Dimensions
N/A
Color options
N/A
Functions
- Treats symptoms resulting from acid reflux
- Relieves heartburn and indigestion
- Prevents acid reflux for up to 4 hours
- Can be used during pregnancy and breastfeeding
Materials
Sodium Alginate, Potassium Bicarbonate
Technical specifications
- Tablet:
- Adults and children over 12 years: 1-2 tablets 3-4 times daily, after meals and before bedtime
- Children 6-12 years: ½-1 tablet 3-4 times daily, after meals and before bedtime
- Suspension:
- Adults and children 12 years and above: 5-10 ml (1-2 teaspoonfuls) 3-4 times daily, after meals and before bedtime
- Children 2-12 years: 2.5-5ml (½-1 teaspoonful) 3-4 times daily, after meals and before bedtime
- Use in children: Not recommended under 2 years of age
- Elderly: No dose modifications necessary
- Hepatic Impairment: No dose modifications necessary
- Renal Insufficiency: Caution if highly restricted salt diet is necessary
Design elements
N/A
Usability features
- Pregnancy & Lactation: Can be used during pregnancy and breastfeeding if clinically needed
- Interaction: A time interval of 2 hours should be considered between intake and the administration of other medicinal products
Precautions warnings
Prescribed with caution in patients with renal impairment and congestive cardiac failure. Care needed in treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal calculi. Reduced efficacy in patients with very low levels of gastric acid. Review the clinical situation if symptoms do not improve after seven days.
Overdose effects
Overdosage with this formulation is a rare case. In case of overdose, consult with a registered physician.
Storage conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Other attributes
- Therapeutic Class: Antacids
- Side Effects: Nausea, constipation, diarrhea, headache; sensation of swelling with too big dosage
- Contraindications: Known hypersensitivity to Sodium Alginate and Potassium Bicarbonate
- Storage: Keep out of the reach of children
Related Brands
- Algicon (500 mg+100 mg)/5 ml (Oral Suspension) - leon-pharmaceuticals-ltd
- Foos (500 mg+100 mg)/5 ml (Oral Suspension) - kumudini-pharma-ltd
- Gerdex (500 mg+100 mg)/5 ml (Oral Suspension) - ibn-sina-pharmaceuticals-ltd
- Viscocid 500 mg+100 mg (Chewable Tablet) - beximco-pharmaceuticals-ltd
- Sodal (500 mg+100 mg)/5 ml (Oral Suspension) - benham-pharmaceuticals-ltd